Navigating Hemorrhagic Shock: Biomarkers, Therapies, and Challenges in Clinical Care
Kenneth Meza Monge, Caleb Rosa, Christopher Sublette, Akshay Pratap, Elizabeth J. Kovacs, Juan-Pablo Idrovo · 2024
Read Navigating Hemorrhagic Shock: Biomarkers, Therapies, and Challenges in Clinical Care by Kenneth Meza Monge, Caleb Rosa, Christopher Sublette, Akshay Pratap, Elizabeth J. Kovacs, Juan-Pablo Idrovo (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11673713.txt.
Description
Kenneth Meza Monge and co-authors review care for hemorrhagic shock, a top cause of preventable death from bleeding. Their 2024 review covers how the body reacts over time, which blood markers help, and which treatments have proof behind them. Injury type shapes the response, so care must fit the pattern.
Early bleeding control, balanced blood products, and a clot-aiding drug given fast form the core of current care. The immune reaction moves in phases, from wide activation to deep suppression. Many targeted molecular drugs remain in trials. The authors call for better markers, sharper timing, and care matched to each patient. They also flag the hard task of bringing new methods into varied care settings.
Catalog record
| CREATOR | Kenneth Meza Monge, Caleb Rosa, Christopher Sublette, Akshay Pratap, Elizabeth J. Kovacs, Juan-Pablo Idrovo |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 40 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |